Ketamine Strengthens CRF-Activated Amygdala Inputs to Basal Dendrites in mPFC Layer v Pyramidal Cells in the Prelimbic but not Infralimbic Subregion, A Key Suppressor of Stress Responses

Neuropsychopharmacology

Volumn 40, Issue 9, 2015, Pages 2066-2075

  Liu, Rong Jian ^a   Ota, Kristie T ^a   Dutheil, Sophie ^a   Duman, Ronald S ^a   Aghajanian, George K ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; EXCITOTOXIN; KETAMINE; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; AMINO ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CINGULATE; ARTICLE; BASAL AMYGDALA; BASOLATERAL AMYGDALA; BRAIN NERVE CELL; CHRONIC UNPREDICTABLE STRESS; CONTROLLED STUDY; DENDRITE; DENDRITIC SPINE; DRUG EFFECT; EXCITATORY POSTSYNAPTIC POTENTIAL; INFRALIMBIC CORTEX; MAJOR DEPRESSION; MALE; MEDIAL PREFRONTAL CORTEX; NONHUMAN; PRELIMBIC CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; RAT; AMYGDALA; ANIMAL; CYTOLOGY; DRUG EFFECTS; IN VITRO STUDY; INJURIES; LIMBIC SYSTEM; NERVE TRACT; PATCH CLAMP TECHNIQUE; PHYSIOLOGY; PREFRONTAL CORTEX; SPRAGUE DAWLEY RAT;

6-CYANO-7-NITROQUINOXALINE-2,3-DIONE; AMYGDALA; ANIMALS; CORTICOTROPIN-RELEASING HORMONE; DENDRITES; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; IN VITRO TECHNIQUES; KETAMINE; LIMBIC SYSTEM; MALE; NEURAL PATHWAYS; PATCH-CLAMP TECHNIQUES; PREFRONTAL CORTEX; PYRAMIDAL CELLS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84937164747     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2015.70     Document Type: Article

References (38)

1. Aghajanian GK, Marek GJ (1997). Serotonin induces excitatory postsynaptic potentials in apical dendrites of neocortical pyramidal cells. Neuropharmacology 36: 589-599.
2. Bacon SJ, Headlam AJ, Gabbott PL, Smith AD (1996). Amygdala input to medial prefrontal cortex (mPFC) in the rat: a light and electron microscope study. Brain Res 720: 211-219.
3. Banasr M, Duman RS (2008). Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biol Psychiatry 64: 863-870.
4. Banasr M, Valentine GW, Li XY, Gourley SL, Taylor JR, Duman RS (2007). Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat. Biol Psychiatry 62: 496-504.
5. Bar-Ilan L, Gidon A, Segev I (2013). The role of dendritic inhibition in shaping the plasticity of excitatory synapses. Front Neural Circuits 6: 118.
6. Berretta S, Pantazopoulos H, Caldera M, Pantazopoulos P, Paré D (2005). Infralimbic cortex activation increases c-Fos expression in intercalated neurons of the amygdala. Neuroscience 132: 943-953.
7. Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al (2000). Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47: 351-354.
8. Cho JH, Deisseroth K, Bolshakov VY (2013). Synaptic encoding of fear extinction in mPFC-amygdala circuits. Neuron 80: 1491-1507.
9. Cook SC, Wellman CL (2004). Chronic stress alters dendritic morphology in rat medial prefrontal cortex. J Neurobiol 60: 236-248.
10. Duman RS, Aghajanian GK (2012). Synaptic dysfunction in depression: potential therapeutic targets. Science 338: 68-72.
11. Gabbott PL, Warner TA, Busby SJ (2006). Amygdala input monosynaptically innervates parvalbumin immunoreactive local circuit neurons in rat medial prefrontal cortex. Neuroscience 139: 1039-1048.
12. Gabbott P, Warner TA, Brown J, Salway P, Gabbott T, Busby S (2012). Amygdala afferents monosynaptically innervate corti-cospinal neurons in rat medial prefrontal cortex. J Comp Neurol 520: 2440-2458.
13. Giesbrecht CJ, Mackay JP, Silveira HB, Urban JH, Colmers WF (2010). Countervailing modulation of Ih by neuropeptide Y and corticotrophin-releasing factor in basolateral amygdala as a possible mechanism for their effects on stress-related behaviors. J Neurosci 30: 16970-16982.
14. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199-214.
15. Krystal JH, Sanacora G, Duman RS (2013). Rapid-acting glutama-tergic antidepressants: the path to ketamine and beyond. Biol Psychiatry 73: 1133-1141.
16. Lambe EK, Aghajanian GK (2003). Hypocretin (orexin) induces calcium transients in single spines postsynaptic to identified thalamocortical boutons in prefrontal slice. Neuron 40: 139-150.
17. Lehmann ML, Herkenham M (2011). Environmental enrichment confers stress resiliency to social defeat through an infralimbic cortex-dependent neuroanatomical pathway. J Neurosci 31: 6159-6173.
18. Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al (2010). mTOR-dependent synapse formation underlies the rapid anti-depressant effects of NMDA antagonists. Science 329: 959-964.
19. Li N, Liu RJ, Dwyer JM, Banasr M, Lee B, Son H et al (2011). Glutamate N-methyl-D-aspartate receptor antagonists rapidly reverse behavioral and synaptic deficits caused by chronic stress exposure. Biol Psychiatry 69: 754-761.
20. Liu RJ, Aghajanian GK (2008). Stress blunts serotonin-and hypocretin-evoked EPSCs in prefrontal cortex: role of corticosterone-mediated apical dendritic atrophy. Proc Natl Acad Sci USA 105: 359-364.
21. Little JP, Carter AG (2013). Synaptic mechanisms underlying strong reciprocal connectivity between the medial prefrontal cortex and basolateral amygdala. J Neurosci 33: 15333-15342.
22. Lu Y, Wang C, Xue Z, Li C, Zhang J, Zhao X et al (2014). PI3K/AKT/mTOR signaling-mediated neuropeptide VGF in the hippocampus of mice involve in the rapid onset antidepressant-like effects of GLYX-13. Int J Neuropsychopharmacol 18: pyu110.
23. Magariños AM, McEwen BS (1995). Stress-induced atrophy of apical dendrites of hippocampal CA3c neurons: involvement of glucocorticoid secretion and excitatory amino acid receptors. Neuroscience 69: 89-98.
24. Marek R, Strobel C, Bredy TW, Sah P (2013). The amygdala and medial prefrontal cortex: partners in the fear circuit. J Physiol 591: 2381-2391.
25. Meltzer HY, Rajagopal L, Huang M, Oyamada Y, Kwon S, Horiguchi M (2013). Translating the N-methyl-D-aspartate receptor antagonist model of schizophrenia to treatments for cognitive impairment in schizophrenia. Int J Neuropsychophar-macol 16: 2181-2194.
26. Moskal JR, Burch R, Burgdorf JS, Kroes RA, Stanton PK, Disterhoft JF et al (2014). GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists. Expert Opin Investig Drugs 23: 243-254.
27. Padival M, Quinette D, Rosenkranz JA (2013). Effects of repeated stress on excitatory drive of basal amygdala neurons in vivo. Neuropsychopharmacology 38: 1748-1762.
28. Price JL, Drevets WC (2010). Neurocircuitry of mood disorders. Neuropsychopharmacology 35: 192-216.
29. Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR et al (2004). Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience 125: 1-6.
30. Rostkowski AB, Leitermann RJ, Urban JH (2013). Differential activation of neuronal cell types in the basolateral amygdala by corticotropin releasing factor. Neuropeptides 47: 273-280.
31. Royer S, Martina M, Paré D (1999). An inhibitory interface gates impulse traffic between the input and output stations of the amygdala. J Neurosci 19: 10575-10583.
32. Senn V, Wolff SB, Herry C, Grenier F, Ehrlich I, Gründemann J et al (2014). Long-range connectivity defines behavioral specificity of amygdala neurons. Neuron 81: 428-437.
33. Sierra-Mercado D, Padilla-Coreano N, Quirk GJ (2011). Dissociable roles of prelimbic and infralimbic cortices, ventral hippocampus, and basolateral amygdala in the expression and extinction of conditioned fear. Neuropsychopharmacology 36: 529-538.
34. Tedesco V, Ravagnani C, Bertoglio D, Chiamulera C (2013). Acute ketamine-induced neuroplasticity: ribosomal protein S6 phos-phorylation expression in drug addiction-related rat brain areas. Neuroreport 24: 388-393.
35. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C et al (2000). Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 428: 191-212.
36. Vialou V, Bagot RC, Cahill ME, Ferguson D, Robison AJ, Dietz DM et al (2014). Prefrontal cortical circuit for depression-and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB. J Neurosci 34: 3878-3887.
37. Weisstaub NV, Zhou M, Lira A, Lambe E, González-Maeso J, Hornung JP et al (2006). Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. Science 313: 536-540.
38. Zarate C, Duman RS, Liu G, Sartori S, Quiroz J, Murck H (2013). New paradigms for treatment-resistant depression. Ann NY Acad Sci 1292: 21-31.